Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.

Kwong A, Shin VY, Ho CYS, Au CH, Slavin TP, Weitzel JN, Chan TL, Ma ESK

Open source

DOI
10.1186/s12885-020-07476-y
Published
2020 Nov 2
Container
BMC cancer
Publisher
figshare
Open access
yes

Credibility signals

uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-020-07476-y,
  title = {Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.},
  author = {Kwong A and Shin VY and Ho CYS and Au CH and Slavin TP and Weitzel JN and Chan TL and Ma ESK},
  year = {2020},
  journal = {BMC cancer},
  doi = {10.1186/s12885-020-07476-y},
  url = {https://doi.org/10.1186/s12885-020-07476-y}
}

RIS

TY  - JOUR
TI  - Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
AU  - Kwong A
AU  - Shin VY
AU  - Ho CYS
AU  - Au CH
AU  - Slavin TP
AU  - Weitzel JN
AU  - Chan TL
AU  - Ma ESK
PY  - 2020
JO  - BMC cancer
DO  - 10.1186/s12885-020-07476-y
UR  - https://doi.org/10.1186/s12885-020-07476-y
ER  -

APA

A, K., VY, S., CYS, H., CH, A., TP, S., JN, W., TL, C., & ESK, M. (2020). Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.. BMC cancer. https://doi.org/10.1186/s12885-020-07476-y

Source records